Peerbridge COR MDx (Cor MDx)
Peerbridge Health, Inc. · Decision date Sep 4, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision for Peerbridge COR MDx (Cor MDx), submission K253529, dated September 4, 2026, with a received date of November 13, 2025. The applicant is Peerbridge Health, Inc.; the device falls under 21 CFR 870.2800, product code MWJ, in the cardiovascular specialty, and the review was abbreviated with no third-party review. SESE is a 510(k) clearance, not a premarket approval.
The cleared device is a retrospective ambulatory ECG recorder with a patient-activated event button, recording external ECG for up to fourteen days for manual retrospective review by qualified clinical personnel. The summary states the device performs no automated arrhythmia detection, real-time analysis, or diagnostic interpretation, and is not intended for ST segment analysis, ischemia detection, or myocardial infarction detection. Substantial equivalence is claimed to the Peerbridge Cor System (K171936); the summary describes the same two-channel acquisition, 200 Hz sampling, 16-bit resolution, 0.5–40 Hz response and electrode geometry, with maximum recording duration extended from seven to fourteen days.
The source does not include the full indications enclosure, clinical performance data, or the predicate's complete labeling, so comparative clinical performance cannot be assessed from these records.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Cardiovascular
- Decision date
- Sep 4, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K253529
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Peerbridge Health, Inc.
- Product code
- MWJ
- Decision code
- SESE
- Decision date
- Sep 4, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Electrocardiograph, Ambulatory (Without Analysis).
- Applicant
- Peerbridge Health, Inc.
- Product code
- MWJ
- FDA device class
- 2
FDA decision timeline
K253529 received
Application receipt date recorded by FDA.
K253529 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code MWJ
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
iCOR BeatK260383 | iCOR Medical, LLC | 510(k) clearance | Nov 2, 2026 | FDA |
| Shenzhen Xinyan Medical Technology Co.,ltd. | 510(k) clearance | Sep 11, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Peerbridge Health, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- New York, NY
Sources and methodology
- Original FDA record: K253529
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records
